Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics

NCT: NCT04130958 · COMPLETED

NCT IDNCT04130958
StatusCOMPLETED
Start Date2023-11-01
Completion2026-05-30
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

This neuroimaging study is a clinical trial investigating the effectiveness of intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) in reducing suicide risk in patients with major depressive episode (MDE) or borderline personality disorder (BPD).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑